Treatments for HSV-2 infections include acyclovir, famciclovir, and valacyclovir. The current CDC recommended options for suppressive therapy of recurrent HSV-2 genital herpes are as follows:
Valacyclovir at 500 mg orally once a day (Valacyclovir at 500 mg once a day might be less effective than other valacyclovir or acyclovir dosing regimens for persons who have frequent recurrences.)
Valacyclovir at 1 gm orally once a day
Acyclovir at 400 mg orally 2 times per day
Famciclovir at 250 mg orally 2 times per day
Penciclovir is a DNA polymerase inhibitor in HSV-1 and HSV-2, with only topical preparations suited for herpes labialis available. Pritelivir has potent and resistance-breaking antiviral activity against HSV-1 and HSV-2 and is being developed for the treatment of acyclovir-resistant and dual-resistant mucocutaneous infections in immune-compromised patients. The therapy has been limited to treating short-term genital herpetic infections.
Learn more about valacyclovir.
Medscape © 2022 WebMD, LLC
Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.
Cite this: Michael Stuart Bronze. Fast Five Quiz: Herpes Simplex Virus - Medscape - Sep 06, 2022.